Statin-associated new-onset diabetes mellitus and insulin resistance: a 30-year bibliometric study (1992- 2022)
Statins are widely used lipid-lowering drugs that are relatively well-tolerated and have an established safety profile. However, statin therapy has been reported to increase the risk of developing new-onset type 2 diabetes mellitus (NOD2). Although this side effect is rare, research on this topic is...
Published in: | Biomedical Research and Therapy |
---|---|
Main Author: | Kamisah Y.; Nordin A.H.; Harafinova H.-S.; Nordin M.L.; Nurhidayah M.; Muhammad N.A.; Qodriyah H.M.S.; Abdullah A.; Mohd-Fahami N.A.; Masbah N.; Siti H.N. |
Format: | Review |
Language: | English |
Published: |
BiomedPress
2023
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85192647030&doi=10.15419%2fbmrat.v10i11.845&partnerID=40&md5=82bdb2aefc20f9440b975365c0cd4451 |
Similar Items
-
Is F2 -isoprostane a biological marker for the early onset of type 2 diabetes mellitus?
by: Kaviarasan S.; Muniandy S.; Qvist R.; Chinna K.; Ismail I.S.
Published: (2010) -
ASSOCIATION BETWEEN INSULIN THERAPY ADHERENCE AND GLYCATED HAEMOGLOBIN (HBA1C) AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS ATTENDING A COMMUNITY HEALTH CLINIC
by: Yahya N.S.; Awang A.; Nordin R.
Published: (2023) -
Application of the Statin-Associated Muscle Symptoms-Clinical Index to a Cohort of Patients With Type 2 Diabetes Mellitus Undergoing Phlebotomy at an Endocrinology Clinic
by: Tajudin N.H.M.; Fahrni M.L.; Ghani R.A.; Awang M.H.; Chopra H.; Alkhoshaiban A.S.
Published: (2024) -
Application of the Statin-Associated Muscle Symptoms-Clinical Index to a Cohort of Patients With Type 2 Diabetes Mellitus Undergoing Phlebotomy at an Endocrinology Clinic
by: Tajudin, et al.
Published: (2024) -
Data Envelopment Analysis and Higher Education: A Systematic Review of the 2018–2022 Literature and Bibliometric Analysis of the Past 30 Years of Literature
by: Ahmad A.M.; Nana Khurizan N.S.
Published: (2024)